Cargando…

Profile of betrixaban and its potential in the prevention and treatment of venous thromboembolism

Venous thromboembolism (VTE), which includes deep vein thrombosis and pulmonary embolism, is a common and potentially preventable cause of morbidity and mortality. Unfractionated heparin, low-molecular-weight heparin, and warfarin have been the cornerstone of VTE prevention and treatment but are bei...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chan, Noel C, Bhagirath, Vinai, Eikelboom, John W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489817/ https://www.ncbi.nlm.nih.gov/pubmed/26170684 http://dx.doi.org/10.2147/VHRM.S63060

Ejemplares similares

Prevention of Venous Thromboembolism in 2020 and Beyond
por: Nicholson, Matthew, et al.
Publicado: (2020)

Betrixaban for prevention of venous thromboembolism in acute medically ill patients
por: Beyer-Westendorf, Jan, et al.
Publicado: (2018)

Current Challenges in Diagnosis of Venous Thromboembolism
por: Liederman, Zachary, et al.
Publicado: (2020)

Pharmacological properties of betrixaban
por: Huisman, Menno V, et al.
Publicado: (2018)

Carbamazepine, phenytoin, and oral anticoagulants: Drug‐drug interaction and clinical events in a retrospective cohort
por: Candeloro, Matteo, et al.
Publicado: (2022)

Plasma Rivaroxaban Level to Identify Patients at Risk of Drug Overexposure: Is a Single Measurement of Drug Level Reliable?
por: Shyamkumar, Krishnan, et al.
Publicado: (2021)

Betrixaban compared with warfarin in patients with atrial fibrillation: results of a phase 2, randomized, dose-ranging study (Explore-Xa)
por: Connolly, Stuart J., et al.
Publicado: (2013)

Testing for Hypercoagulability in Patients With Unexplained Arterial Thromboembolism
por: Chan, Noel, et al.
Publicado: (2023)

Venous Thromboembolism in Patients with Human Immunodeficiency Virus
por: Patel, Kashyap, et al.
Publicado: (2023)

The prevention and treatment of venous thromboembolism with LMWHs and new anticoagulants
por: Blann, Andrew D, et al.
Publicado: (2009)

New Anticoagulants for the Prevention and Treatment of Venous Thromboembolism
por: McRae, Simon J, et al.
Publicado: (2005)

Prevention and treatment of venous thromboembolism in the elderly patient
por: Tincani, Enrico, et al.
Publicado: (2007)

New Anticoagulants for the Prevention and Treatment of Venous Thromboembolism
por: Kim, Joo Hee, et al.
Publicado: (2017)

Prevention and treatment of venous thromboembolism
por: Casadei, Barbara, et al.
Publicado: (2020)

Potential role of new anticoagulants for prevention and treatment of venous thromboembolism in cancer patients
por: Gómez-Outes, Antonio, et al.
Publicado: (2013)

Epidemiology and prevention of venous thromboembolism
por: Lutsey, Pamela L., et al.
Publicado: (2022)

Differentiation of parenteral anticoagulants in the prevention and treatment of venous thromboembolism
por: Fareed, Jawed, et al.
Publicado: (2011)

Factor Xa Inhibitory Profile of Apixaban, Betrixaban, Edoxaban, and Rivaroxaban Does Not Fully Reflect Their Biologic Spectrum
por: Siddiqui, Fakiha, et al.
Publicado: (2019)

New anticoagulants for the prevention of venous thromboembolism
por: Becattini, Cecilia, et al.
Publicado: (2010)

Metabolomic Profile in Venous Thromboembolism (VTE)
por: Franczyk, Beata, et al.
Publicado: (2021)

Cancer‐associated venous thromboembolism: Treatment and prevention with rivaroxaban
por: Bauersachs, Rupert, et al.
Publicado: (2020)

Extended thromboprophylaxis with betrixaban: a new standard for acute medically ill patients
por: Cohen, Alexander T
Publicado: (2018)

Prevention and treatment of venous thromboembolism during HRT: current perspectives
por: Rott, Hannelore
Publicado: (2014)

Shorter or longer anticoagulation to prevent recurrent venous thromboembolism: systematic review and meta-analysis
por: Lopes, Luciane Cruz, et al.
Publicado: (2014)

New insights into the mechanisms of action of aspirin and its use in the prevention and treatment of arterial and venous thromboembolism
por: Mekaj, Ymer H, et al.
Publicado: (2015)

Diet as prophylaxis and treatment for venous thromboembolism?
por: Cundiff, David K, et al.
Publicado: (2010)

Guidelines and Performance Measures for the Prevention and Treatment of Venous Thromboembolism
por: Fanikos, John
Publicado: (2008)

Edoxaban in venous thromboembolism and stroke prevention: an appraisal
por: Proietti, Marco, et al.
Publicado: (2016)

Prevention of venous thromboembolism in ambulatory patients with cancer
por: Khorana, Alok A, et al.
Publicado: (2020)

Thromboelastography for the Prevention of Perioperative Venous Thromboembolism in Orthopedics
por: Fan, Dejing, et al.
Publicado: (2022)

Trends in Perioperative Venous Thromboembolism Associated with Major Noncardiac Surgery
por: Smilowitz, Nathaniel R., et al.
Publicado: (2017)

Apixaban-Calibrated Anti-FXa Activity in Relation to Outcome Events and Clinical Characteristics in Patients with Atrial Fibrillation: Results from the AVERROES Trial
por: Bhagirath, Vinai C., et al.
Publicado: (2017)

Treatment and secondary prevention of venous thromboembolism in cancer
por: Coleman, R, et al.
Publicado: (2010)

Clinical utility of apixaban in the prevention and treatment of venous thromboembolism: current evidence
por: Zalpour, Ali, et al.
Publicado: (2014)

Direct oral anticoagulants for treatment and prevention of venous thromboembolism in cancer patients
por: Song, Andrew B, et al.
Publicado: (2019)

Prevention of venous thromboembolism in patients undergoing bariatric surgery
por: Bartlett, Matthew A, et al.
Publicado: (2015)

Primary prevention of venous thromboembolism in elderly medical patients
por: Lacut, Karine, et al.
Publicado: (2008)

No apparent association between mRNA COVID-19 vaccination and venous thromboembolism
por: Nicholson, Matthew, et al.
Publicado: (2022)

Simultaneous analysis of betrixaban and hexazinone using liquid chromatography/tandem mass spectrometry in aqueous solutions
por: Jasemizad, Tahereh, et al.
Publicado: (2019)

Guidance for the prevention and treatment of cancer-associated venous thromboembolism
por: Khorana, Alok A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_fg7p9fakho5uudtfhp7j1gk77u